Browse Clinical Articles by Topic

Clinical Briefs

Ambulatory BP Monitoring, A New Oral Treatment for Hyperkalemia: Patiromer, Obesity Leads to Overdiagnosis of Airflow Obstruction

Strengthen the Feet to Treat Plantar Fasciitis

SYNOPSIS: A strength training exercise improved self-reported 3-month outcomes in treating plantar fasciitis compared with inserts and stretching.

Effects of Coenzyme Q10 in Chronic Heart Failure Patients

SYNOPSIS: Treatment with coenzyme Q10 in addition to standard therapy for patients with moderate to severe HF is safe, well tolerated, and associated with a reduction in symptoms and major adverse cardiovascular events.

Is BMI Good Enough to Measure Visceral Adiposity?

SYNOPSIS: A large international study found frequent discordance between body mass index (BMI) and waist circumference (WC), driven by the substantial variability in visceral adiposity. Within each BMI category, patients with the highest WC were more likely to have higher cardiometabolic risk.

HPV screening: Option to cytology-based options

Primary human papillomavirus (HPV) screening can be considered as an alternative to current U.S. cytology-based cervical cancer screening methods, according to new interim guidance from the Society of Gynecologic Oncology and the American Society for Colposcopy and Cervical Pathology.¹

Data reaffirm the effectiveness of LNG, copper intrauterine devices

Findings from a recent analysis of data from a large, multi-country study of women using levonorgestrel or copper intrauterine devices (IUDs) indicate that while both forms of contraception have high levels of efficacy, the levonorgestrel device daily releasing 20 mcg (Mirena LNG IUD, Bayer Healthcare Pharmaceuticals, Wayne, NJ) was associated with a significantly lower risk of pregnancy, including ectopic pregnancy, than copper IUDs.¹

New HPV vaccine covers 9 types of HPV

Get ready to include a new human papillomavirus (HPV) vaccine at your facility. The Food and Drug Administration (FDA) has approved Gardasil 9 from Kenilworth, NJ-based Merck Sharp & Dohme Corp., a subsidiary of Merck & Co.

Some groups continue to bear disproportionate burden of STIs

While the latest national surveillance data show signs of progress in reducing chlamydia and gonorrhea among young people ages 15-24, the numbers and rates of reported cases of these two diseases continue to be highest in this group compared to other age groups.¹

Research focuses on health implications tied to PCOS

Women diagnosed with polycystic ovary syndrome (PCOS) face an elevated risk of developing heart disease, diabetes, mental health conditions, reproductive disorders, and cancer of the lining of the uterus.

More emphasis needed on vaccination for HPV — What is your approach?

A new analysis of national data indicates about half of girls in the United States receive the human papillomavirus (HPV) vaccine at the recommended age.